[SATB1表达和临床病理特征与扩散型大B细胞淋巴瘤的预后之间的关系]

Jie Sun1, Guang-Yao Yu2, Sha He1

  • 1Department of Hematology/Oncology and Pediatric Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

PubMed
概括

在扩散型大B细胞淋巴瘤 (DLBCL) 中,特定的AT序列结合蛋白1 (SATB1) 表达与更好的结果有关. 在DLBCL患者中,较高的SATB1水平与良好的预后和较低的ECOG分数相关.